about
Advances in liver transplantation allocation systemsFecal Calprotectin is an Accurate Tool and Correlated to Seo Index in Prediction of Relapse in Iranian Patients With Ulcerative Colitis.Review on immunosuppression in liver transplantation.Fourteen Years of Experience of Liver Transplantation for Wilson's Disease; a Report on 107 Cases from Shiraz, IranMultiplex ARMS PCR to Detect 8 Common Mutations of ATP7B Gene in Patients With Wilson Disease.Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction.Health Related Quality of Life in Iranian Patients With Irritable Bowel Syndrome: Reliability and Validity of the Persian Version of the IBS-QOL.Liver transplantation for inherited metabolic disorders of the liver.Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.Evaluation of Adrenal Function in Nonhospitalized Patients with CirrhosisA new ATP7B gene mutation with severe condition in two unrelated Iranian families with Wilson disease.Effect of fluid therapy on prevention of acute renal failure in Bam earthquake crush victims.Combined liver kidney transplantation: critical analysis of a single-center experience.The frequency and distribution of thiopurine S-methyltransferase alleles in south Iranian population.Low Dose Intradermal Versus High Dose Intramuscular Hepatitis B Vaccination in Patients on Chronic HemodialysisAssociation Between Tacrolimus Concentration and Genetic Polymorphisms of CYP3A5 and ABCB1 During the Early Stage After Liver Transplant in an Iranian PopulationHyponatremia a valuable predictor of early mortality in patients with cirrhosis listed for liver transplantationPotential benefit of angiotensin converting enzyme inhibitors for hindering progression of graves’ ophthalmopathy
P50
Q26766076-48B00C6D-8AE9-43BB-9314-9741D1CE4FAEQ35157904-B79E12C3-3FFF-4ACC-8029-F8748249F366Q35668757-6801C0B1-EAEF-4CC7-8E7C-D3E210E0E701Q36216217-A2626A92-0849-48B2-B52C-104BC4F7DCB4Q37121833-22008CA6-9967-4790-A94A-CC378304C256Q37158806-2DC54524-0D4B-4FDD-B51A-91CB45CE7BB3Q37569190-4283C608-F55F-42D0-B956-10E2A871DD03Q37758124-6005B2F9-2E86-41FB-9EFD-34934BE383F6Q39651256-007A1D7E-075E-4B91-AE68-A408B079CA31Q41216716-53FB6CD0-5340-4B48-8725-08F1B48829ADQ41275296-EA05CEB8-0BB1-4203-B8B2-F1103AA47C2EQ43843954-79A14F12-E01C-47D0-B1AD-FB0E083A4BF2Q46092706-B747641E-8AAE-4F48-AD9B-79DF194C406EQ50556697-3F822B30-6278-42E1-A592-DED02DA6C3EAQ54347571-3652DDEB-2BE8-48A7-8110-5FBB4A55C1C5Q54989537-237AF605-D2CC-464C-B590-B1AD87218605Q60458853-77E280F6-5D16-4C4C-8DA2-474E9A3A3248Q60668620-B99F149E-C26D-407E-B4C1-6019589E6D31Q60668627-852352AD-FBC3-4FF0-9776-F93EB1FF0685
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Maryam Moini
@ast
Maryam Moini
@en
Maryam Moini
@es
Maryam Moini
@nl
Maryam Moini
@sl
type
label
Maryam Moini
@ast
Maryam Moini
@en
Maryam Moini
@es
Maryam Moini
@nl
Maryam Moini
@sl
prefLabel
Maryam Moini
@ast
Maryam Moini
@en
Maryam Moini
@es
Maryam Moini
@nl
Maryam Moini
@sl
P106
P1153
8379032000
P21
P31
P496
0000-0001-9619-4206